Fibronection (FN) is a glycoprotein whose plasma concentrations are reduced in many pathological conditions. In patients with hemoblastosis plasma FN was correlated with some clinical and biological parameters (stage of the disease, hepatosplenomegaly, infections and DIC), in order to assess its value as a tumor marker. The results suggest a poor relationship between FN levels and the course of the disease. However, the behaviour of the protein in relation with treatment was dynamic.
MosessonM.W., AmraniD.L.The structure and biologic activities of plasma fibronectin. Blood1980; 56: 145–58.
2.
MosherD.F., GrossmanJ.E.Clinical use of fibronectin. La Ricerca Clin Lab1983; 13: 43–53.
3.
LanserM.E., SabaT.M.Opsonic fibronectin deficiency and sepsis: cause or effect?Ann Surg1982; 195: 340–5.
4.
ChoateJ.J., MosherD.F.Fibronectin concentration in plasma of patients with breast cancer, colon cancer and acute leukemia. Cancer1983; 51: 1142–7.
5.
StathakisN.E., FountasA., TsianosE.Plasma fibronectin in normal subjects and in various disease states. J Clin Pathol1981; 34: 504–8.
6.
CoulardJ.M., LabrousseJ., SalmonaJ.P.Plasma fibronectin concentrations in critically ill patients. La Ricerca Clin Lab1982; 12: 137–41.
7.
MosherD.F., WilliamsE.M.Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation. J Lab Clin Med1978; 91: 729–35.
8.
CurciG., FrassoldatiA., ZioniF.Dosaggio della fibronectina nei linfomi. In: CajozzoA., PerriconeR., eds.: Attualità in Ematologia.Monduzzi Ed., Bologna. 1985, p. 945 sgg.
9.
BoughtonB.J., SimpsonA.Plasma fibronectin in acute leukemia. Brit J Haematol1982; 51: 487–91.
